Utility of PCD Diagnostics to Improve Clinical Care
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: f
View:
• Referred to center for PCD diagnosis considerations
• Ability to perform study procedures
• Age greater than 2 years of age
Locations
United States
Tennessee
Vanderbilt Children's hospital
RECRUITING
Nashville
Contact Information
Primary
Michael O'Connor, MD
michael.g.oconnor@vumc.org
615.343.7617
Time Frame
Start Date: 2017-06-01
Estimated Completion Date: 2028-06-01
Participants
Target number of participants: 200
Treatments
Other: Nasal Nitric Oxide testing and collection of clinical data
Participants will have nNO testing is indicated. All participants in this study have some basic clinical data collected at time of enrollment. Participants with a confirmed diagnosis of PCD or in those participants with a working diagnosis of PCD in which ongoing nNO testing is performed have prospective data collection. Some participants have a confirmed diagnosis of PCD by genetics or ciliary biopsy at time of study entry and thus do not need nNO testing, but are followed prospectively with collection of basic clinical data
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University Medical Center